You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HB sAg Hepatitis B surface antigen

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Resolved Hepatitis B, CD20 Positive B-cell Lymphoma Trial (Entecavir)

Not yet recruiting
  • Resolved Hepatitis B
  • CD20 Positive B-cell Lymphoma
  • (no location specified)
Jul 10, 2022

Chronic Hepatitis B Trial in Zhengzhou (continuous treatment, pulse therapy)

Recruiting
  • Chronic Hepatitis B
  • continuous treatment
  • pulse therapy
  • Zhengzhou, Henan, China
    Henan Provincial People's Hospital
Jul 13, 2022

Australian Hepatitis and Risk Survey in Prisons

Recruiting
  • Hepatitis C
  • +2 more
  • Point-of-care hepatitis C antibody test
  • +5 more
  • Hume, Australian Capital Territory, Australia
  • +23 more
Apr 20, 2023

Hepatitis B Trial in Cambridge (GSK's Hepatitis B vaccine adjuvanted with aluminum hydroxide, GSK's HBsAg candidate vaccine

Recruiting
  • Hepatitis B
  • GSK's Hepatitis B vaccine adjuvanted with aluminum hydroxide
  • +4 more
  • Cambridge, United Kingdom
    GSK Investigational Site
Jan 12, 2023

Chronic Hepatitis B Trial in Melbourne (162, Placebo)

Recruiting
  • Chronic Hepatitis B
  • 162
  • Placebo
  • Melbourne, Australia
    Nucleus Network Pty Ltd
Jun 5, 2022

Hepatitis B, Chronic Trial in Worldwide (Entecavir (ETV), Tenofovir Disoproxil Fumarate (TDF), Tenofovir Alafenamide (TAF))

Withdrawn
  • Hepatitis B, Chronic
  • Entecavir (ETV)
  • +2 more
  • Kolding, Denmark
  • +29 more
Oct 27, 2022

Chronic Hepatitis B Trial in Zhengzhou (PegIFN a- 2b)

Completed
  • Chronic Hepatitis B
  • PegIFN α- 2b
  • Zhengzhou, Henan, China
    Henan Provincial People's Hospital
Jul 11, 2022

Hepatitis B Trial in Baltimore, Falls Church (Hepatitis B Vaccine Recombinant, Adjuvanted Intramuscular Solution [HEPLISAV-B])

Withdrawn
  • Hepatitis B
  • Hepatitis B Vaccine Recombinant, Adjuvanted Intramuscular Solution [HEPLISAV-B]
  • Baltimore, Maryland
  • +1 more
Jul 19, 2022

Hepatitis B, Chronic Trial in Guangzhou (pegylated interferon-alfa)

Recruiting
  • Hepatitis B, Chronic
  • pegylated interferon-alfa
  • Guangzhou, Guangdong, China
    Department of Infectious Diseases, The Third Affliated Hospital
Dec 20, 2021

Cirrhosis, Liver, Vaccination Failure, HBV Trial (IMIQUIMOD cream, HEPATITIS B SURFACE ANTIGEN)

Not yet recruiting
  • Cirrhosis, Liver
  • +3 more
  • IMIQUIMOD cream
  • HEPATITIS B SURFACE ANTIGEN
  • (no location specified)
Aug 27, 2021

Chronic Hepatitis B Trial in Amsterdam (Peg-Interferon alfa 2a + Adefovir dipivoxil, Peg-Interferon alfa 2a + Tenofovir

Completed
  • Chronic Hepatitis B
  • Peg-Interferon alfa 2a + Adefovir dipivoxil, Peg-Interferon alfa 2a + Tenofovir disoproxil fumarate
  • Amsterdam, Noord-Holland, Netherlands
    Academic Medical Center
Mar 25, 2021

Chronic Hepatitis b Trial in Taipei (Spirulina)

Completed
  • Chronic Hepatitis b
  • Spirulina
  • Taipei, Wenshan District, Taiwan
    Wanfang Hospital
Jan 20, 2021

Hepatitis B, Chronic Trial in Worldwide (JNJ-73763989, JNJ-64300535, ETV monohydrate)

Active, not recruiting
  • Hepatitis B, Chronic
  • Edegem, Belgium
  • +12 more
Jan 17, 2023

Hepatitis B, Chronic Trial in Worldwide (JNJ-73763989, PD-1 inhibitor, Tenofovir Disoproxil)

Recruiting
  • Hepatitis B, Chronic
  • Vancouver, British Columbia, Canada
  • +31 more
Jan 17, 2023

Hepatitis B, Chronic Trial in Worldwide (JNJ-73763989, PegIFN-alpha-2a, Tenofovir disoproxil)

Terminated
  • Hepatitis B, Chronic
  • Hillsborough, New Jersey
  • +11 more
Dec 28, 2022

Hepatitis B Trial in Worldwide (JNJ-56136379, Placebo, NA (ETV or TDF))

Completed
Has Results
  • Hepatitis B
  • Bakersfield, California
  • +75 more
Oct 24, 2022

Lung Transplant, Hepatitis B Trial (Hepatitis B Immune Globulin and entecavir, tenofovir disoproxil, or tenofovir alafenamide)

Recruiting
  • Lung Transplant
  • Hepatitis B
  • Hepatitis B Immune Globulin and entecavir, tenofovir disoproxil, or tenofovir alafenamide
  • Philadelphia, Pennsylvania
    Hospital of University of Pennsylvania
Oct 1, 2022

Hepatitis B Trial in Worldwide (GSK3228836, Nucleos(t)ide therapy)

Recruiting
  • Hepatitis B
  • Boston, Massachusetts
  • +3 more
Aug 24, 2022

Hepatitis B, Chronic Trial in Toronto (Tenofovir disoproxil fumarate)

Active, not recruiting
  • Hepatitis B, Chronic
  • Tenofovir disoproxil fumarate
  • Toronto, Ontario, Canada
    University Health Network - Toronto General Hospital
Nov 1, 2022

Hepatitis B, Chronic Trial in Worldwide (HepTcell, Placebo)

Recruiting
  • Hepatitis B, Chronic
  • HepTcell
  • Placebo
  • Garden Grove, California
  • +20 more
Dec 1, 2021

Chronic Hepatitis B Trial (Imdusiran (AB-729))

Not yet recruiting
  • Chronic Hepatitis B
  • Imdusiran (AB-729)
  • (no location specified)
Nov 30, 2023

Functional Cure of Hepatitis B in HIV/HBV Co-infected Patients

Recruiting
  • AIDS
  • Hepatitis B
  • Peginterferon alfa-2b Injection
  • Guangzhou, Guangdong, China
    Guangzhou Eighth People's Hospital, Guangzhou Medical University
Aug 10, 2023

HBeAg-negative CHB Patients With Indeterminate Phase

Recruiting
  • Chronic Hepatitis b
  • Observation
  • Antiviral treatment
  • Changzhou, Jiangsu, China
  • +4 more
Dec 21, 2022

Chronic Hepatitis B Trial (HRS9950 tablets, HRS9950 tablets)

Not yet recruiting
  • Chronic Hepatitis B
  • HRS9950 tablets
  • HRS9950 placebo tablets
  • (no location specified)
Jun 7, 2023

Chronic Hepatitis B Trial in Hong Kong (Treatment cessation)

Completed
  • Chronic Hepatitis B
  • Treatment cessation
  • Hong Kong, Hong Kong
    Department of Medicine, The University of Hong Kong, Queen Mary
Feb 6, 2020